Navigation Links
Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
Date:9/25/2008

eases including breast and uterine cancers, heart disease, stroke and blood clots," said Dr. Tagliaferri. "Independent studies have shown that the major reason postmenopausal women refrain from sexual activity is due to vaginal dryness. Considering the lack of safe treatment options for this indication, and given the data we have developed on this drug candidate, VG101 could be a superior treatment for the millions of women who want to improve both their quality of life as well as sexual functioning."

The North American Menopause Society (NAMS) is the leading nonprofit organization dedicated to promoting the health and quality of life of menopausal women. NAMS has a multidisciplinary membership of over 2,000 leaders in the field of women's health.

About VG101

VG101 is an intravaginal drug designed for the treatment of vaginal atrophy and dryness in menopausal women. VG101 is a novel estrogen receptor beta selective agonist and unlike currently available hormone therapies, does not activate the estrogen receptor alpha, which is known to be implicated in both breast and uterine tumor formation. Phase 1/2 clinical testing of VG101, under the directorship of Dr. Deborah Grady, will commence within the next year.

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more inf
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... TOKIO , July 13, 2014 /PRNewswire/ ... Juli in Tokio ... der firmenseitigen Bemühungen zur Neuausrichtung seines Forschungsrahmenprogramms. ... umfassenden Überblick über die fortgeschrittenen klinischen Programme ... Das Ziel der Tagung bestand darin, aktuelle ...
(Date:7/13/2014)...  Eli Lilly and Company (NYSE: ... study in genetically engineered mice examining combination therapy ... N3pG and beta-secretase inhibitor BACE (LY2811376). Data results ... removing clumps of amyloid-beta protein in the brain ... to Alzheimer,s disease (AD) – than use of ...
(Date:7/11/2014)... /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a new ... in portable vaporizers, which contains CBD, or cannabodiol. ... cannabidiol offers consumers a THC-free product made for ... technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... compounds which are currently known, two of which ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
... July 26 Halt Medical, Inc. announced ... been appointed to its Scientific Advisory Board.  Dr. Rubin ... to develop and implement comprehensive reimbursement strategies.  Dr. Rubin,s ... of medicine, government, and business. Currently, he is Clinical ...
... Reportlinker.com announces that a new market research report is available in its ... 2008 U.S. Diabetes Drug Delivery - ... http://www.reportlinker.com/p0236248/2008-US-Diabetes-Drug-Delivery---Patient-Perspective.html , ... This study encompasses feedback provided by U.S. diabetes patients ...
Cached Medicine Technology:Dr. Robert J. Rubin to Join Halt Board as Reimbursement Advisor 22008 U.S. Diabetes Drug Delivery - Patient Perspective 22008 U.S. Diabetes Drug Delivery - Patient Perspective 32008 U.S. Diabetes Drug Delivery - Patient Perspective 42008 U.S. Diabetes Drug Delivery - Patient Perspective 5
(Date:7/13/2014)... Genetics identifies a novel genetic and molecular ... (EoE), opening up potential new therapeutic strategies for ... EoE is a chronic inflammatory disorder of the ... to certain foods and an over-accumulation in the ... of the body,s immune system). EoE can cause ...
(Date:7/13/2014)... inexpensive, portable, microchip-based test for diagnosing type-1 diabetes ... better understand the disease, according to the device,s ... , Described in a paper to be published ... the test employs nanotechnology to detect type-1 diabetes ... the two main forms of diabetes mellitus, which ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Chromatography ... biological components from various types of biological samples ... separate the sample mixture into two phase, namely ... the mobile phase run over the stationary phase, ... the components that provide the separation of mixture. ...
(Date:7/13/2014)... Recently, MillionaireCasket.com, a well-known casket manufacturer from China, has ... the company’s chief executive officer has announced a new promotion ... offered at discounted prices, from 15 to 26 percent off. ... in huge demand in the current market. We are excited ... a lot of high quality products for sale. Many of ...
(Date:7/13/2014)... Vancouver, BC (PRWEB) July 13, 2014 ... creating excitement by promoting the rental of bikes for ... the historic downtown Victorian Hotel to tour the area ... day, plus tax. Bicycle enthusiasts love to call Vancouver ... many options for cycle travel and picturesque journeys through ...
Breaking Medicine News(10 mins):Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 2Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 3Health News:Stanford researchers invent nanotech microchip to diagnose type-1 diabetes 4Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3Health News:Cheap Oak Caskets Recently Unveiled By China Casket Manufacturer MillionaireCasket.com 2Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2
... the Y chromosome uses a neat trick to repair its ... from rotting away over evolutionary time. ,The Y chromosome, of ... makes males rather than females. ,Some scientists have suggested ... can't eliminate genetic defects in the usual way,// and broken ...
... Health Organisation said the world should be free of the ... but warned the disease could emerge in China again next ... within the next two-to-three weeks. SARS will be gone, we ... the only two areas still regarded as zones where the ...
... the onset of prostate cancer, however, finasteride may also ... men were randomized , age 55 or older to ... examination results were normal in all subjects, and prostate-specific ... Among the 4368 men in the finasteride group treated ...
... about something, let it out and it might save ... headaches internalize their anger more than those without headaches. ... study, 171 suffered from headaches. Investigators measured //trait anger ... hostility, anxiety and depression. Participants also provided information about ...
... vitamin D. ,Each year, 200,000 women in the United States ... form of the vitamin may enhance the effect of radiation ... with radiation alone to mice exposed to both radiation and ... tumor volume in those women treated //with EB 1089 was ...
... is most likely to be deadly when tumor cells spread ... a protein that may be able to predict a tumor’s ... ,Researchers from the University of Michigan Comprehensive Cancer Center are ... cancer cells to leave their original location and enter nearby ...
Cached Medicine News:Health News:Y chromosome uses trick to repair its own genes 2Health News:World SARS-free within weeks 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: